When monitoring a client on chlorpromazine, what would indicate that the medication is effective?

When monitoring a client on chlorpromazine, what would indicate that the medication is effective?

• A. Increased energy levels
• B. Decreased hallucinations
• C. Less anxiety
• D. Improved sleeping patterns

Answer: (B)

The effectiveness of chlorpromazine, an antipsychotic medication, can be particularly indicated by a decrease in hallucinations. Chlorpromazine primarily targets symptoms associated with psychosis, including hallucinations and delusions. A reduction in these symptoms reflects the medication's action on the neurotransmitter systems, particularly dopamine, which is implicated in psychotic disorders. While increased energy levels, less anxiety, and improved sleeping patterns can also suggest improvements in a client's overall mental health or medication response, they are not direct indicators of the specific antipsychotic effects of chlorpromazine. Decreasing hallucinations directly correlates with the intended therapeutic effect of the medication, making it the most appropriate choice for evaluating its efficacy in treating conditions such as schizophrenia or other severe mental health disorders.

The effectiveness of chlorpromazine, an antipsychotic medication, can be particularly indicated by a decrease in hallucinations. Chlorpromazine primarily targets symptoms associated with psychosis, including hallucinations and delusions. A reduction in these symptoms reflects the medication's action on the neurotransmitter systems, particularly dopamine, which is implicated in psychotic disorders.

While increased energy levels, less anxiety, and improved sleeping patterns can also suggest improvements in a client's overall mental health or medication response, they are not direct indicators of the specific antipsychotic effects of chlorpromazine. Decreasing hallucinations directly correlates with the intended therapeutic effect of the medication, making it the most appropriate choice for evaluating its efficacy in treating conditions such as schizophrenia or other severe mental health disorders.